NAT Diagnostics
San Diego, US · Founded 2014 · Delaware corporation
Founders & leadership
AP
Andrew P. MillerExecutive
Board
DJ
David J. GalasBoard director
TW
Thomas WuBoard director
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 2 rounds · 2015–2017
▶$1.5MraisedNov 2017 · 18 investors · BiotechnologyRule 506(b)
▶$1.5MraisedNov 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas WuDirector
- David J. GalasDirector
- Allan FanDirector
- Andrew P. MillerExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $12.2K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.9MraisedSep 2015 · 18 investors · BiotechnologyRule 506(b)
▶$2.9MraisedSep 2015 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David J. GalasDirector
- Andrew P. MillerExecutive Officer, Director
- Thomas WuDirector
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- Minimum investment
- $5K
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has NAT Diagnostics raised?
- NAT Diagnostics has disclosed $4.4M raised across 2 rounds.
- Where is NAT Diagnostics headquartered?
- NAT Diagnostics is headquartered in San Diego, US.